(Report ID: 63058) Drug interactions analysis of: Levitra, Avodart, Multi-vitamin, Tylenol (caplet)Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,647 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 10 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 63058 | Dec, 30, 2005 | 59 | Male |
List of drugs the patient takes:
| Drug |
Levitra |
Avodart |
Multi-vitamin |
Tylenol (caplet) |
List of drug interactions, adverse side effects / events the patient has:
| Name |
Erectile Dysfunction |
Results from eHealthMe: 10 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Erectile Dysfunction | 3 (30.00%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Drug Administration Error | 1 (100.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Razadyne | 1 |
2 | Nitroglycerin | 1 |
3 | Sertraline | 1 |
4 | Toprol-xl | 1 |
5 | Zyprexa | 1 |
6 | Namenda | 1 |
7 | Lipitor | 1 |
8 | Allopurinol | 1 |
9 | Aspirin | 1 |
10 | Furosemide | 1 |
4) Top drug interactions, adverse side effects reported of all time:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Erectile Dysfunction | 3 (30.00%) |
2 | Headache | 3 (30.00%) |
3 | Dizziness | 2 (20.00%) |
4 | Drug Ineffective | 2 (20.00%) |
5 | Increased Upper Airway Secretion | 1 (10.00%) |
6 | Treatment Noncompliance | 1 (10.00%) |
7 | Pharyngolaryngeal Pain | 1 (10.00%) |
8 | Urine Flow Decreased | 1 (10.00%) |
9 | Dyspnoea | 1 (10.00%) |
10 | Fatigue | 1 (10.00%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Viagra | 5 |
2 | Singulair | 3 |
3 | Androgel | 3 |
4 | Clonazepam | 3 |
5 | Testosterone | 3 |
6 | Omeprazole | 2 |
7 | Furosemide | 2 |
8 | Flomax | 2 |
9 | Meclizine | 2 |
10 | Lipitor | 2 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Glycopyrrolate for Hyperhidrosis (Nov, 21, 2008)
|
Toprol-xl (Astrazeneca) - EQ 25MG TAR... for Irregular Heartbeat (Nov, 21, 2008)
|
Lyrica (Cp Pharms) - 50MG for Nerve Inflammation (Nov, 21, 2008)
|
Side effects comparison of Ultram (Nov, 21, 2008)
|
Side effects comparison of Xanax (Nov, 21, 2008)
|
Side effects comparison of Aspirin (Nov, 21, 2008)
|
Side effects comparison of Ativan (Baxter Hlthcare Corp) - 2MG/ML (Nov, 21, 2008)
|
Side effects comparison of Lamictal (Glaxosmithkline) - 100MG (Nov, 21, 2008)
|
Side effects comparison of Percocet (Nov, 21, 2008)
|
Side effects comparison of Percocet (Nov, 21, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|